erlotinib hydrochloride has been researched along with zn(ii)-phthalocyanine in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (zn(ii)-phthalocyanine) | Trials (zn(ii)-phthalocyanine) | Recent Studies (post-2010) (zn(ii)-phthalocyanine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 445 | 2 | 290 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Li, J; Liu, JY; Xue, JP; Zhang, FL; Zheng, K | 1 |
| Huang, MD; Huang, Q; Liu, JY; Xue, JP; Zhang, FL | 1 |
2 other study(ies) available for erlotinib hydrochloride and zn(ii)-phthalocyanine
| Article | Year |
|---|---|
A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
Topics: Antineoplastic Agents; Drug Delivery Systems; Erlotinib Hydrochloride; Ethylene Glycol; Hep G2 Cells; Humans; Indoles; Isoindoles; Neoplasms; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Quinazolines; Zinc Compounds | 2013 |
Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Drug Design; ErbB Receptors; Erlotinib Hydrochloride; Hep G2 Cells; Humans; Indoles; Isoindoles; Light; Liver Neoplasms; Microscopy, Confocal; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Quinazolines; Structure-Activity Relationship; Zinc Compounds | 2015 |